Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety
MT Mascellino, F Di Timoteo… - Infection and drug …, 2021 - Taylor & Francis
This review takes into consideration the principal vaccines developed against the SARS-
CoV-2 in this unprecedented period of Covid-19 pandemic. We evaluated the mechanism of …
CoV-2 in this unprecedented period of Covid-19 pandemic. We evaluated the mechanism of …
Exploration of nanozymes in viral diagnosis and therapy
Nanozymes are nanomaterials with similar catalytic activities to natural enzymes. Compared
with natural enzymes, they have numerous advantages, including higher physiochemical …
with natural enzymes, they have numerous advantages, including higher physiochemical …
Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine
The first two mRNA vaccines against infection by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) that were approved by regulators require a cold chain and …
coronavirus 2 (SARS-CoV-2) that were approved by regulators require a cold chain and …
Zn‐MOF encapsulated antibacterial and degradable microneedles array for promoting wound healing
An infected skin wound caused by external injury remains a serious challenge in clinical
practice. Wound dressings with the properties of antibacterial activity and potent …
practice. Wound dressings with the properties of antibacterial activity and potent …
Platforms for production of protein-based vaccines: from classical to next-generation strategies
R Cid, J Bolívar - Biomolecules, 2021 - mdpi.com
To date, vaccination has become one of the most effective strategies to control and reduce
infectious diseases, preventing millions of deaths worldwide. The earliest vaccines were …
infectious diseases, preventing millions of deaths worldwide. The earliest vaccines were …
[HTML][HTML] Nanovaccines: a game changing approach in the fight against infectious diseases
The field of nanotechnology has revolutionised global attempts to prevent, treat, and
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …
Nanocarrier vaccines for SARS-CoV-2
The SARS-CoV-2 global pandemic has seen rapid spread, disease morbidities and death
associated with substantive social, economic and societal impacts. Treatments rely on re …
associated with substantive social, economic and societal impacts. Treatments rely on re …
Gold-nanostar-chitosan-mediated delivery of SARS-CoV-2 DNA vaccine for respiratory mucosal immunization: development and proof-of-principle
The COVID-19 pandemic is caused by the coronavirus SARS-CoV-2 (SC2). A variety of anti-
SC2 vaccines have been approved for human applications, including those using …
SC2 vaccines have been approved for human applications, including those using …
Mechanisms of COVID-19 pathogenesis in diabetes
C Aluganti Narasimhulu… - American Journal of …, 2022 - journals.physiology.org
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) virus, is a global pandemic impacting 254 million people in …
coronavirus 2 (SARS-CoV-2) virus, is a global pandemic impacting 254 million people in …
Immune response to SARS-CoV-2 vaccines
N Bellamkonda, UP Lambe, S Sawant, SS Nandi… - Biomedicines, 2022 - mdpi.com
COVID-19 vaccines have been developed to confer immunity against the SARS-CoV-2
infection. Prior to the pandemic of COVID-19 which started in March 2020, there was a well …
infection. Prior to the pandemic of COVID-19 which started in March 2020, there was a well …